Albert Kolomansky

Tel Aviv, TA 69978, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Erythropoietin and bone health: Single high-dose administration triggers bone loss in mice.

Erythropoietin and bone health: Single high-dose administration triggers bone loss in mice.

Journal: Bone reports

Published: July 22, 2025

The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer.

The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer.

Journal: International journal of molecular sciences

Published: April 03, 2023

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice.

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice.

Journal: International journal of molecular sciences

Published: August 14, 2022

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

Journal: International journal of molecular sciences

Published: November 22, 2021

Unraveling a Nosocomial Outbreak of COVID-19: The Role of Whole-Genome Sequence Analysis.

Unraveling a Nosocomial Outbreak of COVID-19: The Role of Whole-Genome Sequence Analysis.

Journal: Open forum infectious diseases

Published: January 15, 2021

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS.

A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS.

Journal: Blood advances

Published: December 18, 2020

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice.

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice.

Journal: Frontiers in immunology

Published: May 12, 2020

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible.

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible.

Journal: International journal of molecular sciences

Published: April 29, 2020

Erythropoietin receptor in B cells plays a role in bone remodeling in mice.

Erythropoietin receptor in B cells plays a role in bone remodeling in mice.

Journal: Theranostics

Published: March 10, 2020

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients.

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients.

Journal: Acta haematologica

Published: August 23, 2019

Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts.

Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts.

Journal: The Israel Medical Association journal : IMAJ

Published: October 17, 2018

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.

Journal: Bone marrow transplantation

Published: June 06, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026